Immunic Says It Bolstered Balance Sheet Through Three-tranche Private Placement Totaling Up To $240M, Extending Cash Runway Into Q3 2025, Based On Initial $80M Tranche
Immunic Says It Bolstered Balance Sheet Through Three-tranche Private Placement Totaling Up To $240M, Extending Cash Runway Into Q3 2025, Based On Initial $80M Tranche
Immunic表示,根據最初的8000萬美元資金,它通過總額高達2.4億美元的三批私募來增強資產負債表,將現金流延至2025年第三季度
Immunic Says It Bolstered Balance Sheet Through Three-tranche Private Placement Totaling Up To $240M, Extending Cash Runway Into Q3 2025, Based On Initial $80M Tranche
Immunic表示,根據最初的8000萬美元資金,它通過總額高達2.4億美元的三批私募來增強資產負債表,將現金流延至2025年第三季度